NCT01672255View on ClinicalTrials.gov

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Type 1 DiabetesHypoglycemia Associated Autonomic Failure
Interventions
DRUG

Fluoxetine

20 mg week 1, 40 mg week 2, 60 mg week 3, 80 mg week 4-6

DRUG

Placebo control

20 mg Week 1, 40 mg Week 2, 60 mg Week 3, 80 mg Week 4-6

Trial Locations (1)

21201

University of Maryland, Baltimore, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT01672255 - Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM) | Biotech Hunter | Biotech Hunter